Valuation: Celltrion Pharm, Inc.

Market Cap 4,674B 6,294,328B 4,153B 3,876B 3,533B 6,662B 449,294B 6,724B 46,903B 18,175B 229,685B 17,547B 17,166B 737,143B P/E 2019
166x
P/E 2020 417x
Enterprise Value 4,837B 6,514,219B 4,298B 4,011B 3,656B 6,895B 464,990B 6,959B 48,542B 18,810B 237,709B 18,160B 17,766B 762,894B EV / Sales 2019
9.06x
EV / Sales 2020 38x
Free-Float
44.16%
Yield 2019 *
-
Yield 2020 -
1 day-3.15%
1 week-1.66%
Current month+0.79%
1 month-6.00%
3 months-8.35%
6 months-29.54%
Current year-33.79%
1 week 37,800
Extreme 37800
39,900
1 month 37,800
Extreme 37800
41,250
Current year 37,000
Extreme 37000
78,300
1 year 37,000
Extreme 37000
78,300
3 years 37,000
Extreme 37000
124,463.12
5 years 37,000
Extreme 37000
124,463.12
10 years 13,660.97
Extreme 13660.974887
221,035.48
Manager TitleAgeSince
Chief Executive Officer 61 25/03/2024
Director of Finance/CFO 53 -
Sales & Marketing 55 -
Director TitleAgeSince
Chairman 69 27/03/2025
Chairman 42 25/03/2024
Director/Board Member 61 25/03/2024
Date Insider Type Main position Quantity % Market Cap. Importance
07/05/25 Others 24 0.0001%
07/05/25 Others 127 0.0003%
07/05/25 Exercice 4,500 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-3.15%-1.66%-27.60%-35.36% 1.26B
-0.61%-3.43%+36.07%+117.61% 1,019B
-1.02%-5.60%+35.72%+64.82% 617B
+1.11%-0.58%+12.36%+78.27% 464B
+0.34%-3.01%+61.79%+41.79% 356B
-0.95%-4.05%+20.54%+40.33% 333B
-1.46%-2.89%+10.57%+26.54% 267B
-1.35%-5.43%-6.17%+8.82% 244B
-1.04%-2.79%+35.30%+54.42% 218B
-1.87%-4.10%+28.44%+97.54% 179B
Average -1.00%-3.29%+20.70%+49.48% 369.84B
Weighted average by Cap. -0.60%-3.33%+29.05%+71.12%

Financials

2019 2020
Net sales 174B 233,680B 154B 144B 131B 247B 16,680B 250B 1,741B 675B 8,527B 651B 637B 27,367B 234B 314,561B 208B 194B 177B 333B 22,454B 336B 2,344B 908B 11,479B 877B 858B 36,839B
Net income 8.6B 11,585B 7.64B 7.13B 6.5B 12.26B 827B 12.38B 86.33B 33.45B 423B 32.3B 31.6B 1,357B 20.94B 28,201B 18.6B 17.36B 15.83B 29.85B 2,013B 30.13B 210B 81.43B 1,029B 78.62B 76.91B 3,303B
Net Debt 149B 200,066B 132B 123B 112B 212B 14,281B 214B 1,491B 578B 7,301B 558B 546B 23,430B 163B 219,891B 145B 135B 123B 233B 15,696B 235B 1,639B 635B 8,024B 613B 600B 25,752B
Logo Celltrion Pharm, Inc.
Celltrion Pharm Inc is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The Company’s products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. It also provides ethical drugs and over-the-counter (OTC) drugs. The Company distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.
Employees
328
Date Price Change Volume
02/10/26 ₩38,400.00 -3.15% 99,025
01/10/26 ₩39,650.00 +4.07% 120,590
30/09/26 ₩38,100.00 -1.30% 91,304
29/09/26 ₩38,600.00 -1.91% 116,563
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A068760 Stock